Li-Yu Zhao

Development and validation of dual-time-window readmission prediction models under China’s medical insurance multi-payment reform

Background Readmission is an important indicator of healthcare quality, reflecting continuity of care, treatment outcomes, and the quality of discharge management. However, existing readmission prediction studies have primarily focused on 30-day readmission as the primary outcome, with limited attention to differences...